UBS maintained a Buy rating and increased the price target for Rapid7 on August 16, 2025.
2 reports, 1 independent
Updated Aug 16
Gone quiet
- Reports
- 2
- Developments
- 2
- Repetition
- 0%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
UBS maintained a Buy rating and increased the price target for Rapid7 on August 16, 2025.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.UBS maintained a Buy rating and raised the price target for Rapid7.1 source
- UBS increased price target and maintained Buy rating for Spot on July 9, 2025.
Keep exploring
The entities involved
-
UBS
Swiss multinational investment bank and financial services company
-
Rapid7
developer of the Metasploit Framework
Nothing else this week.
-
Spot
Japanese business
Nothing else this week.
Related events
- Assembly Biosciences stock traded on Nasdaq, while UBS cut its price target but maintained a Buy rating, following an SEC disclosure.
- Investec, UBS, and Macquarie issued positive recommendations and high target prices for Bharat Electronics Limited (BEL) on July 1, 2026.
- UBS upgraded Lockheed Martin to 'Buy' status, while MarketWatch and MarketBeat reported on L3Harris stock and AI initiatives.
- Wholesale Club filed a disclosure document with the SEC, coinciding with UBS increasing its price target.
- Citigroup and UBS raised their price targets for Procter & Gamble.
Coverage
Newest first; wire copies grouped- Insider MonkeyUBS Boosts Rapid7 (RPD) Price Target Despite Modest Q2 Revenue Growth Rapid7, Inc. (NASDAQ:RPD) is one of the most undervalued cybersecurity stocks to buy now. On August 8, UBS maintained its Buy rat
- Unknown outlet